Certificate of Analysis
Independent laboratory testing confirms purity and composition of this research peptide.
Endo Passed
Overview
Cagrilintide is a synthetic analog of amylin, a 37-amino acid peptide hormone that is naturally co-secreted with insulin from pancreatic beta cells. Cagrilintide was designed as a long-acting version of the native amylin molecule, with specific amino acid substitutions and an acylation — the attachment of a fatty acid chain — that slows its clearance from solution.
The compound has the molecular formula C194H312N54O59S2, a molecular weight of approximately 4,409 g/mol, and a CAS number of 1415456-99-3. It is classified as an acylated amylin receptor agonist. Cagrilintide is supplied as a white lyophilized powder that is soluble in water. The key structural modification is the fatty acid sidechain, which enables albumin binding and extends the molecule’s half-life substantially compared to native amylin, which breaks down within minutes in solution.
This product is strictly for research purposes only. Not approved for human or animal use.
PubChem Reference: View compound profile on NIH PubChem
Key Characteristics
MOLECULAR PROFILE
Formula: C194H312N54O59S2
Weight: 4,409 g/mol
CAS: 1415456-99-3
Structure: Modified amylin analog
PHYSICAL PROPERTIES
Form: White lyophilized powder
Solubility: Soluble in water
Half-life: Extended compared to native amylin
Storage: Keep refrigerated 36‑46 °F (2‑8 °C)
